Fox A, Oliva J, Vangipurapu R, Sverdrup F
Skelet Muscle. 2024; 14(1):30.
PMID: 39627769
PMC: 11613756.
DOI: 10.1186/s13395-024-00361-3.
Moriggi M, Ruggiero L, Torretta E, Zoppi D, Arosio B, Ferri E
Antioxidants (Basel). 2024; 13(11).
PMID: 39594549
PMC: 11591206.
DOI: 10.3390/antiox13111406.
Arends T, Hamm D, van der Maarel S, Tapscott S
Cold Spring Harb Perspect Biol. 2024; .
PMID: 39009417
PMC: 11733064.
DOI: 10.1101/cshperspect.a041492.
Kucinski J, Calderon D, Kendall G
Dis Model Mech. 2024; 17(6).
PMID: 38916046
PMC: 11225592.
DOI: 10.1242/dmm.050704.
Nguyen T, Limpens M, Bouhmidi S, Paprzycki L, Legrand A, Decleves A
Int J Mol Sci. 2024; 25(6).
PMID: 38542301
PMC: 10969790.
DOI: 10.3390/ijms25063327.
Voluntary wheel running improves molecular and functional deficits in a murine model of facioscapulohumeral muscular dystrophy.
Bittel A, Bittel D, Gordish-Dressman H, Chen Y
iScience. 2024; 27(1):108632.
PMID: 38188524
PMC: 10770537.
DOI: 10.1016/j.isci.2023.108632.
Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.
Nguyen T, Paprzycki L, Legrand A, Decleves A, Heher P, Limpens M
Skelet Muscle. 2023; 13(1):21.
PMID: 38104132
PMC: 10724930.
DOI: 10.1186/s13395-023-00330-2.
Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping.
Guruju N, Jump V, Lemmers R, van der Maarel S, Liu R, Nallamilli B
Neurol Genet. 2023; 9(6):e200107.
PMID: 38021397
PMC: 10664978.
DOI: 10.1212/NXG.0000000000200107.
Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism.
Cohen J, Huang S, Koczwara K, Woods K, Ho V, Woodman K
Cell Death Dis. 2023; 14(11):749.
PMID: 37973788
PMC: 10654915.
DOI: 10.1038/s41419-023-06257-2.
FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation.
Engquist E, Greco A, Joosten L, van Engelen B, Zammit P, Banerji C
Hum Mol Genet. 2023; 33(2):182-197.
PMID: 37856562
PMC: 10772042.
DOI: 10.1093/hmg/ddad175.
PITX1 plays essential functions in cancer.
Zhao J, Xu Y
Front Oncol. 2023; 13:1253238.
PMID: 37841446
PMC: 10570508.
DOI: 10.3389/fonc.2023.1253238.
Deciphering D4Z4 CpG methylation gradients in fascioscapulohumeral muscular dystrophy using nanopore sequencing.
Butterfield R, Dunn D, Duval B, Moldt S, Weiss R
Genome Res. 2023; 33(9):1439-1454.
PMID: 37798116
PMC: 10620044.
DOI: 10.1101/gr.277871.123.
The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy.
Banerji C, Greco A, Joosten L, van Engelen B, Zammit P
Brain Commun. 2023; 5(5):fcad221.
PMID: 37731904
PMC: 10507741.
DOI: 10.1093/braincomms/fcad221.
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
Lemmers R, Butterfield R, van der Vliet P, De Bleecker J, van der Pol L, Dunn D
Brain. 2023; 147(2):414-426.
PMID: 37703328
PMC: 10834250.
DOI: 10.1093/brain/awad312.
Molecular and Phenotypic Changes in FLExDUX4 Mice.
Murphy K, Zhang A, Bittel A, Chen Y
J Pers Med. 2023; 13(7).
PMID: 37511653
PMC: 10381554.
DOI: 10.3390/jpm13071040.
SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action.
Sikrova D, Testa A, Willemsen I, van den Heuvel A, Tapscott S, Daxinger L
Commun Biol. 2023; 6(1):677.
PMID: 37380887
PMC: 10307901.
DOI: 10.1038/s42003-023-05053-0.
Influence of Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments.
Duranti E, Villa C
Int J Mol Sci. 2023; 24(11).
PMID: 37298453
PMC: 10253551.
DOI: 10.3390/ijms24119503.
Nutritional Status of Patients with Facioscapulohumeral Muscular Dystrophy.
Amzali S, Wilson V, Bommart S, Picot M, Galas S, Mercier J
Nutrients. 2023; 15(7).
PMID: 37049513
PMC: 10096775.
DOI: 10.3390/nu15071673.
The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins.
Claus C, Slavin M, Ansseau E, Lancelot C, Bah K, Lassche S
Skelet Muscle. 2023; 13(1):5.
PMID: 36882853
PMC: 9990282.
DOI: 10.1186/s13395-022-00310-y.
Facioscapulohumeral muscular dystrophy: the road to targeted therapies.
Tihaya M, Mul K, Balog J, de Greef J, Tapscott S, Tawil R
Nat Rev Neurol. 2023; 19(2):91-108.
PMID: 36627512
PMC: 11578282.
DOI: 10.1038/s41582-022-00762-2.